English
Amractionfund
  • About Us
    • Mission
    • Strategy
    • Who we are
    • Investors
    • Testimonials
  • AMR Innovation Challenge
    • The threat of AMR
    • The pipeline problem
    • A sustainable pipeline
    • The role of the fund
  • Our Investments
    • How it works
    • Scope of our investments
    • Stewardship and Access Principles
    • Our Portfolio
  • Resources
  • Contact Us

      Resources

      Filter by category:
      • All
      • Applications
      • Fund Resources
      • In the News
      • News
      • Newsletters
      • Press Releases
      4 Apr, 2022

      AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals

      AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals   Deals mark an important...

      Read More
      1 Feb, 2022

      AMR Action Fund Appoints Scientific Advisory Board

      This move brings the Fund, launched one year ago, one step closer to delivering 2 to 4 new antibiotics to...

      12 Oct, 2021

      Antibiotic resistance in the patient with cancer

      The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.

      21 Sep, 2021

      The AMR Action Fund Appoints Bill Burns as Board Chair

      This move brings the Fund, launched one year ago, one step closer to delivering 2 to 4 new antibiotics to...

      30 Jul, 2021

      AMR Action Fund July Newsletter...

      AMR Action Fund July Newsletter

      15 Jul, 2021

      The AMR Action Fund Appoints John H. Rex, MD as Chair of its Sc...

      This move brings the Fund, launched one year ago, one step closer to delivering 2 to 4 new antibiotics to...

      4 May, 2021

      AMR Action Fund May Newsletter...

      AMR Action Fund May Newsletter

      18 Feb, 2021

      The AMR Action Fund announces its first non-industry investment...

      18 Feb, 2021

      The AMR Action Fund announces appointment of CEO, Henry B. Skin...

      4 Dec, 2020

      A research and development fund for new treatments for bacteria...

      The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.

      Show More
      Amractionfund
      © 2022 AMR Action Fund All rights reserved. |
      • Japan Disclaimer
      • Privacy Policy